Christoph Brackmann - 04 Nov 2025 Form 4 Insider Report for NovoCure Ltd (NVCR)

Role
Chief Financial Officer
Signature
Steven Robbins, as attorney in fact for Brackmann, Christoph
Issuer symbol
NVCR
Transactions as of
04 Nov 2025
Net transactions value
-$86,014
Form type
4
Filing time
04 Nov 2025, 16:10:10 UTC
Previous filing
30 Jul 2025
Next filing
05 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Brackmann Christoph Chief Financial Officer C/O NOVOCURE INC., 1550 LIBERTY RIDGE DRIVE, SUITE 115, WAYNE Steven Robbins, as attorney in fact for Brackmann, Christoph 04 Nov 2025 0002048634

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCR Ordinary Shares Tax liability $86,014 -7,033 -5% $12.23 134,117 04 Nov 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares required to be withheld by the issuer to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This transaction is not discretionary and approved as required pursuant to Rules 16b-3(e) and 16b-3(d)(1).